Feedback / Questions
Nebulized Ampion (aspartyl-alanyl diketopiperazine) - Ampio
https://www.prnewswire.com/news-releases/ampio-pharmaceuticals-receives-investigational-review-board-approval-for-its-phase-i-long-covid-19-trial-ap-018-301287097.html
May 10, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next